This company seems to have been delisted
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Reason: Acquired by Neuphoria Therapeutics
Last recorded trade on: February 25, 2025
Source: https://www.nasdaq.com/articles/neuphoria-therapeutics-inc-completes-scheme-arrangement-bionomics-limiteds-re
Bionomics
BNOX
HK$1.96
Share price
4.59%
Change (1 day)
-75.41%
Change (1 year)
Categories
Revenue for Bionomics (BNOX)
Revenue in 2024 (TTM): HK$5.14 Million
According to Bionomics's latest financial reports the company's current revenue (TTM 
) is HK$5.14 Million. In 2023 the company made a revenue of HK$0.11 Million a decrease over the revenue in the year 2022 that were of HK$2.04 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bionomics from 2001 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | HK$5.14 M | 4444.2% |
| 2023 | HK$0.11 M | -94.46% |
| 2022 | HK$2.04 M | |
| 2021 | N/A | -100% |
| 2020 | HK$0.24 M | -98.81% |
| 2019 | HK$20.83 M | -3.35% |
| 2018 | HK$21.55 M | -32.74% |
| 2017 | HK$32.04 M | -20.8% |
| 2016 | HK$40.46 M | 2.56% |
| 2015 | HK$39.45 M | -71.78% |
| 2014 | HK$0.13 B | 1104.64% |
| 2013 | HK$11.6 M | 29.74% |
| 2012 | HK$8.94 M | -66.11% |
| 2011 | HK$26.4 M | 35.15% |
| 2010 | HK$19.53 M | -13.48% |
| 2009 | HK$22.58 M | 169.83% |
| 2008 | HK$8.36 M | 55.88% |
| 2007 | HK$5.36 M | 42.82% |
| 2006 | HK$3.75 M | 114.87% |
| 2005 | HK$1.74 M | |
| 2004 | N/A | -100% |
| 2003 | HK$5.32 M | -24.09% |
| 2002 | HK$7.01 M | 195.12% |
| 2001 | HK$2.37 M |